In vivo assessment of Intrasynaptic dopamine in Parkinson patients following treatment with L-dopa or L-dopa/entacapone

被引：0
|
作者：
Seibyl, JP
Tabamo, R
Jennings, D
Tamagnan, G
Rabinowicz, A
Marek, K
机构：
来源：
MOVEMENT DISORDERS | 2005年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P149
引用
收藏
页码：S44 / S45
页数：2
相关论文
共 50 条
  • [21] URINARY METABOLITES OF L-DOPA DURING LONG-TERM TREATMENT OF PARKINSONIAN PATIENTS WITH L-DOPA
    SIIRTOLA, T
    SONNINEN, V
    RINNE, UK
    ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1972, 31 : 66 - &
  • [22] L-DOPA IN TREATMENT OF PARKINSONISM
    HALEEM, MA
    GERONTOLOGIA CLINICA, 1972, 14 (04): : 242 - 248
  • [23] Amblyopia: Treatment with L-Dopa?
    不详
    OPHTHALMOLOGE, 2016, 113 (06): : 455 - 455
  • [24] L-DOPA IN TREATMENT OF PARKINSONISM
    BREZNY, I
    CERNACEK, J
    BURANOVA, D
    TRAVNIKOVA, M
    ACTIVITAS NERVOSA SUPERIOR, 1972, 14 (02): : 96 - +
  • [25] L-DOPA IN TREATMENT OF PARKINSONISM
    CALNE, DB
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1970, 11 (06) : 789 - +
  • [26] TREATMENT OF PARKINSONISM WITH L-DOPA
    PRESTHUS, J
    ACTA NEUROLOGICA SCANDINAVICA, 1970, 46 : 220 - &
  • [27] Peculiarities of L-DOPA treatment of Parkinson’s disease
    R. M. Kostrzewa
    P. Nowak
    J. P. Kostrzewa
    R. A. Kostrzewa
    R. Brus
    Amino Acids, 2005, 28 : 157 - 164
  • [28] URINARY METABOLITES OF L-DOPA DURING LONG-TERM TREATMENT OF PARKINSONIAN PATIENTS WITH L-DOPA
    SIIRTOLA, T
    HIRVIAHO, L
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1973, 31 : 14 - 14
  • [29] MEASURING L-DOPA IN PLASMA AND URINE TO MONITOR THERAPY OF ELDERLY PATIENTS WITH PARKINSON DISEASE TREATED WITH L-DOPA AND A DOPA DECARBOXYLASE INHIBITOR
    DUTTON, J
    COPELAND, LG
    PLAYFER, JR
    ROBERTS, NB
    CLINICAL CHEMISTRY, 1993, 39 (04) : 629 - 634
  • [30] Entacapone improves the availability of L-dopa in plasma by decreasing its peripheral metabolism independent of L-dopa/carbidopa dose
    Heikkinen, H
    Varhe, A
    Laine, T
    Puttonen, J
    Kela, M
    Kaakkola, S
    Reinikainen, K
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 54 (04) : 363 - 371
12345